India Patent Cases
2,847 decisions indexed
Page 70 of 95 · 2,847 total
Mount Everest Breweries Limited v.State of Madhya Pradesh
Mount Everest Breweries Limited and United Breweries Limited filed a Writ Petition challenging the inaction of the State of Madhya Pradesh regarding the infringement of their IP rights. The petitioners alleged that unauthorized breweries were illegally using their registered trademarks, designs, and copyrighted artistic features on bottles, often replacing them with products from other manufacturers. This practice was causing significant losses and consumer risk due to faulty bottling. The High Court disposed of the petition by directing the State authorities to take appropriate action and provide a reasoned response to the petitioners' prior representations within sixty days.
Bayer Intellectual Property GmbH & Anr. v.Titan Laboratories Pvt. Ltd.
Bayer Intellectual Property GmbH and its associates filed a suit alleging that Titan Laboratories Pvt. Ltd. was infringing on their patented compound, Rivaroxaban (IN 211300). The plaintiff contended that the defendant was exporting finished pharmaceutical products containing Rivaroxaban to foreign entities in commercial quantities. Despite the lack of domestic launch by the defendant, the court held that such exports constituted 'use in India' under the Patents Act. Consequently, the Delhi High Court granted an ad-interim ex-parte injunction in favor of Bayer.
Astrazenca Ab v.Ajanta Pharma Ltd.
The court heard an application seeking condonation of a 6-day delay by the defendant, which was granted. The court also directed the parties regarding the filing of written statements and clarified the validity dates of the two patents (IN '147 and IN '625) held by Astrazenca Ab.
Astrazenca Ab & Anr v.West Coast Pharmaceuticals Works Ltd.
The Delhi High Court heard the matter concerning suit patents held by Astrazenca Ab & Anr against West Coast Pharmaceuticals Works Ltd. The court addressed the validity dates of the two patents (IN '147 and IN '625) and accepted an undertaking from the defendant that they do not manufacture or sell infringing products related to Dapagliflozin.
Merck Sharp And Dohme Corp. v.Honour Lab Limited
Merck Sharp And Dohme Corp. filed a suit alleging that Honour Lab Limited was infringing their Indian Patent No. 209816, which covers the molecule SITAGLIPTIN (an API for diabetes treatment). The plaintiffs sought interim relief against the defendant's alleged commercial supply of the patented API.
Ms Industries And Spirits P Ltd v.M/S. Allied Blenders And Distillers Pvt ...
This appeal challenged the grant of ex parte ad interim injunctions by the City Civil Court, Hyderabad. The original suit involved allegations of trademark and copyright infringement (passing off) concerning alcoholic beverages, specifically comparing 'Officer's Choice' with 'Manjeera Classic No.1 Whisky'. However, the Telangana High Court did not rule on the merits of the IP dispute but instead focused on procedural lapses. The court found that the lower court failed to record reasons for granting the ex parte injunctions as mandated by law, leading to the setting aside and remittance of the orders.
Ms Industries And Spirits P Ltd v.M/S. Allied Blenders And Distillers Pvt ...
This appeal challenged the grant of ex parte ad interim injunctions by the City Civil Court, Hyderabad. The original suit involved allegations of trademark and copyright infringement (passing off) concerning alcoholic beverages, specifically comparing 'Officer's Choice' with 'Manjeera Classic No.1 Whisky'. However, the Telangana High Court ultimately set aside these injunction orders, finding that the lower court failed to provide reasons for granting the ex parte relief as mandated by law.
Laurus Labs Limited v.Intellectual Property Appellate Board
The petitioner seeks to quash an interim order by the IPAB that stayed the revocation of a patent. The case involves a post-grant opposition filed by the petitioner against the patent granted to respondent No.3.
Sterlite Technologies Limited v.Ztt India Private Limited
The plaintiff sought the discovery of two sets of documents from the defendant: those concerning the manufacturing process of optical fibre and sales data. The court allowed the discovery of sales documents, requiring the defendant to file its audited balance sheet. However, the court denied the immediate necessity of discovering the manufacturing process documents, stating that the initial burden of proof remains with the plaintiff.
Shogun Organics Ltd v.Gaur Hari Guchhait & Ors
The case involves a patent infringement dispute where the Plaintiff was granted a permanent injunction and compensation for loss of profits. The Defendants were directed to render accounts of profits and pay a specified amount to the Plaintiff.
Bristol-Myers Squibb Holdings Ireland Unlimited Company v.Bdr Pharmaceuticals International Pvt. Ltd & Anr.
The plaintiffs filed an application seeking action under Contempt of Court because defendant No.1 submitted a tender offering for the sale of Apixaban, despite a prior interim injunction restraining them from dealing in any infringing product covered by Indian Patent No. IN 247381. The court issued show cause notices to the Chairman and Director of defendant No.1 regarding potential contempt proceedings.
Triumphant Institute Of Management Education Pvt. Ltd. v.Mega Limited & Ors.
The Delhi High Court addressed a copyright infringement suit filed by Triumphant Institute of Management against Mega Limited. The court acknowledged the plaintiff's claims regarding its registered trademark 'TIME' and copyrighted study materials. However, recognizing the intermediary status of the defendant, the court issued an interim order stipulating that the defendant must take down infringing content only upon receiving specific notice (URLs) from the plaintiff, aligning with safe harbor provisions under the IT Act.
Shogun Organics Ltd v.Gaur Hari Guchhait & Ors.
The suit was originally filed by Shogun Organics Ltd seeking permanent injunction against infringement of its process patent (IN236630) related to D-TRANS ALLETHRIN. The current application sought permission to sell existing manufactured stock prior to the final judgment. The court allowed the sale but directed the defendants to pay 5% of the sales value and deposit costs.
Merck Sharp & Dohme Corp. v.Angels Pharma India Private Limited
Merck Sharp & Dohme Corp. filed a suit alleging that Angels Pharma India Private Limited was attempting to manufacture and infringe its Indian Patent No. 209816, which covers the drug SITAGLIPTIN. The court found that the plaintiffs had established a prima facie case and granted interim relief.
Sun Mobility Private Limited v.Mr. Arumugam Rajpendra Babu
The appeal challenged an order that appointed a Scientific Advisor to adjudicate a dispute over patent infringement. The plaintiff claimed his patents covered specific EV battery charging systems, while defendants were accused of infringing with 'quick interchange station' technology. The High Court confirmed the single judge's order appointing the Scientific Advisor and dismissed the appeal.
SAP SE v.ERP TRAINING INDIA & ORS.
SAP SE successfully secured a comprehensive interim injunction against ERP Training India and associated parties in the Delhi High Court. The court found prima facie evidence of trademark and copyright infringement related to unauthorized online SAP training courses. Consequently, the defendants were ordered to immediately deactivate websites, domains, email addresses, block specific IP access points, and freeze bank accounts linked to the infringing activities.
Monsanto Holdings Private Limited v.Competition Commission Of India
This appeal challenges a single judge's decision that appellants (Monsanto) were governed by both the Competition Act, 2002, and the Patents Act, 1970. The core dispute revolves around whether competition law proceedings are applicable when patented seeds are involved. The court allowed several applications and issued an interim restraint on the CCI from finalizing its report pending further hearing.
Bayer Intellectual Property Gmbh & Anr v.Morepen Laboratories Ltd
Bayer Intellectual Property Gmbh filed a suit against Morepen Laboratories Ltd alleging infringement of its Indian Patent No. 211300, which covers Rivaroxaban. The defendant admitted to making commercial use before expiry due to a miscommunication regarding the patent's expiration date. Both parties agreed that the suit could be decreed in terms of permanent injunction, leading to the final disposal of the case.
Monsanto Holdings Private Limited v.Competition Commission Of India
Monsanto Holdings Private Limited challenged several orders issued by the Competition Commission of India (CCI) concerning allegations of unfair trade practices related to the 'trait fee' charged for using Bt. Cotton technology. The core dispute revolved around the licensing terms and recurring fees imposed by MMBL, a subsidiary in India. The Delhi High Court dismissed the petitions, finding no reason to interfere with the CCI's administrative orders, provided they were not arbitrary or unreasonable.
Merck Sharp & Dohme Corp And Anr v.Oceanic Pharmachem Pvt. Ltd.
The plaintiffs filed a suit alleging that the defendant was infringing their Indian Patent No. 209816, which covers Sitagliptin and its salts. The plaintiff submitted evidence showing the defendant's online presence advertising and selling infringing Sitagliptin Phosphate API in India. Based on this prima-facie case, the court granted an ad-interim injunction restraining the defendant from dealing in the infringing product.
Kamal Kishore Arora v.Central Public Information Officer, Trade Marks Registry
The appellant filed an RTI application seeking detailed particulars of trade mark registration applications that were unlawfully accepted, withdrawn, and the subsequent disciplinary action taken against concerned Examiners. The CPIO initially denied providing certain information citing exemptions under the RTI Act. The Commission found the CPIO's reply misleading regarding complaints received by the organization and directed a revised response.
Pfizer Inc v.Kwality Pharmaceuticals Limited
Pfizer Inc filed a suit against Kwality Pharmaceuticals Limited alleging infringement of two Indian Patents, IN 209251 (Sunitinib) and IN 268331 (Tigecycline composition). The defendants agreed to the permanent injunction and offered compensation. The court decreed the suit in favor of the plaintiffs.
Sungro Seeds Ltd v.Sk Tripathi & Ors
Sungro Seeds Ltd filed a suit alleging that its ex-employees misappropriated confidential information, including parent lines and breeding strategies for its hybrid cauliflower 'Katreena', which was then used by a competitor to market an identical variety named 'Riya'. The core dispute centered on the unauthorized use of trade secrets and unfair competition. However, the Delhi High Court ultimately dismissed the suit, holding that without prior registration under the Protection of Plant Varieties and Farmers' Rights Act, 2001 (PPVFR Act), the plaintiff could not maintain a suit to restrain infringement.
Merck Sharp & Dohme Corp. v.Everest Organics Limited
Merck Sharp & Dohme Corp. filed a suit seeking permanent injunction against Everest Organics Limited for infringing its registered patent No. 209816, which covers the molecule SITAGLIPTIN. The Plaintiffs alleged that the Defendant was developing and preparing to commercialize an infringing product. Based on the prima facie case presented, the Court granted an ad-interim ex-parte injunction.
Pfizer Inc. v.Everest Pharmaceuticals Ltd.
Pfizer Inc. filed a suit seeking permanent injunction against Everest Pharmaceuticals Ltd. for infringement of Indian Patents Nos. 241773 and 218212, which cover Tofacitinib (XELJANZ(R)). The plaintiffs alleged that defendants were illegally manufacturing and selling generic versions under the brand 'TOFAXEN'.
Kanishk Sinha v.Union Of India
The Calcutta High Court disposed of the writ petitions filed by Kanishk Sinha against the Union of India. The court noted that the petitioner's patent application had been accepted online, substantially addressing his grievance.
Merck Sharp & Dohme Corp. v.Achemic Pharmaceuticals (India) Pvt. Ltd.
The plaintiffs, holding patents and licenses for Sitagliptin (under trade names ISTAVEL and ISTAMET), filed a suit alleging that the defendant was manufacturing and selling the drug under the brand name TwoTrack, thereby infringing their patent. The court found that the plaintiffs had made out a prima facie case and granted an ex parte ad interim injunction.
Prof. Dr. Claudio De Simone & Next Gen Pharma India Pvt. Ltd. v.Actial Farmaceutica Srl. (Formerly known as CD Investment Srl.) & Ors.
The plaintiffs, claiming ownership over the 'De Simone Formulation' through patent rights and subsequent Know-How agreements, filed suit against CD Group entities. The core dispute revolved around whether the plaintiff retained proprietary rights (trade secrets) after the initial patent expired in 2015. The court ultimately dismissed the suit, holding that without a valid patent right in India, the plaintiffs lacked a personal cause of action to restrain the defendants from working or selling the formulation.
Merck Sharp & Dohme Corp. v.Triveni Interchem Private Limited
The plaintiff, Merck Sharp & Dohme Corp., filed a suit alleging that the defendant, Triveni Interchem Private Limited, was selling and advertising various compositions of Sitagliptin without taking any license. The plaintiff holds a valid patent for Sitagliptin.
Bharat Bhogilal Patel v.Nokia Corporations & Ors
The appellant filed a Regular First Appeal against a judgment decreeing the suit instituted by the respondent/plaintiff. The original suit declared that the processes and machinery used by the plaintiff did not infringe the appellant's patents (189027 and 188787) and granted permanent injunction restraining the appellant from threatening infringement proceedings. The appeal was dismissed primarily due to the failure of the appellant to prove sufficient cause for condoning the inordinate delay.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.